Subscribe to press release roundup

To regularly receive important releases about Endeavour Vision and portfolio companies

Title *
First name *
Last name *
E-mail *
 
April 10, 2014
CommProve confirm its strong presence in LATAM

 
April 10, 2014
CeQur Appoints Douglas Lawrence Chief Executive Officer

 
April 8, 2014
Epigenetic Cancer Therapy Clears Phase I

 
March 24, 2014
Amplidata Secures $11M to Drive Next Phase of Growth

 
March 5, 2014
Diabetes Care Publishes Data Demonstrating PaQ® Insulin Delivery Device Could Help People with Type 2 Diabetes Overcome Barriers to Insulin Adherence and Improve Clinical Outcomes

 
January 22, 2014
Sakura Internet Cloud Datacenter Deploys Amplidata Object Store for Cloud Archiving, Backup, and Content Delivery Services

 
January 8, 2014
CeQur to Present at the 32nd Annual J.P. Morgan Healthcare Conference

 
December 4, 2013
Roche and Molecular Partners enter into alliance to develop new cancer treatments

 
December 2, 2013
Blackhawk Network Acquires Germany-Based Prepaid Leader Retailo as Part of Ongoing International Expansion Strategy

 
November 19, 2013
Spartoo test driver of the European Google Trusted Store program

 
November 13, 2013
Amplidata Named a Leader in IDC MarketScape for Object-Based Scale-Out Storage

 
October 28, 2013
Symetis Announces a Symbolic Milestone - the 1000th Patient Implanted with ACURATE TA™

 
October 28, 2013
French Cost-Effectiveness Trial of PneumRx RePneu LVR Coil Fully Enrolled in Record Time

 
October 8, 2013
CommProve Announces New Mobile Operator Win in Asia

 
September 26, 2013
Symetis and Endoluminal Sciences enter into a license agreement to develop 3rd generation TAVI

 
September 24, 2013
Data Demonstrating Potential Benefits of Simple Insulin Delivery Device Presented at European Association for the Study of Diabetes Annual Meeting

 
September 19, 2013
BIND Therapeutics Announces Pricing of Initial Public Offering

 
September 18, 2013
CommProve Wins $2.7M New Business in Africa

 
September 9, 2013
CeQur SA Closes $27 Million Series B Financing

 
August 27, 2013
BIND Recognized by the World Economic Forum as a Technology Pioneer

 
August 19, 2013
BIND Doses First Patient in a Phase 2 Clinical Study of BIND-014 in Prostate Cancer

 
August 12, 2013
BIND Therapeutics Files Registration Statement for Proposed Initial Public Offering

 
August 12, 2013
Symetis announces successful, first time implantation of i ts ACURATE TA™ and ACURATE TF™ TAVI systems in Japan

 
July 31, 2013
Merz Pharma takes over Swiss dermatology specialist Neocutis

 
July 19, 2013
Amplidata Chosen To Archive Music Legends Performances Live And In High Definition At Montreux Jazz Festival 2013

 
July 10, 2013
Kobojo Unleashes Mutants: Genetic Gladiators

 
July 8, 2013
OncoEthix Closes 18 Million CHF (~US$19 Million) Series B Financing

 
July 3, 2013
Tesla Lee Joins CommProve as VP of Sales, Asia Pacific

 
June 22, 2013
New Data Demonstrate Simple Insulin Delivery Device Can Significantly Reduce Barriers to Insulin Treatment Among People with Type 2 Diabetes

 
June 7, 2013
Kobojo Names Mario Rizzo CEO, Reveals New Mid-Core Game, Mutants: Genetic Gladiators

 
June 4, 2013
CommProve Releases Guide to Effective LTE Management

 
May 22, 2013
CommProve Launches Mobile Broadband Insight for LTE

 
May 15, 2013
TIM Brasil Awards CommProve $1.2M LTE Network Monitoring Expansion Contract

 
April 22, 2013
BIND Therapeutics and AstraZeneca Announce Worldwide Development and Commercialization Agreement for Cancer Nanomedicine

 
April 19, 2013
Robert Muhaw Joins CommProve as VP of Professional Services

 
April 3, 2013
BIND Therapeutics Announces Global Collaboration with Pfizer to Develop and Commercialize Multiple Accurins

 
April 3, 2013
Symetis' ACURATE TA(TM) Confirms Superior Results

 
February 28, 2013
CeQur Announces Positive Results from Study Evaluating Simple Insulin Delivery Device Among People with Type 2 Diabetes

 
January 17, 2013
Molecular Partners Announces Publication of Results from a Phase I/II Clinical Trial of its

 
January 9, 2013
Amplidata’s AS36 Named Storage Visions 2013 Award Winner

 
January 8, 2013
BIND Biosciences and Amgen Sign Agreement For The Worldwide Development and Commercialization of a Kinase Inhibitor Nanomedicine

 
November 27, 2012
CeQur Receives CE Mark for PaQ® Insulin Delivery Device

 
November 15, 2012
TAGSYS RFID is a finalist for the 2012 Red Herring 100 Global Award

 
November 7, 2012
CommProve Wins Prestigious BBTM Congress Award 2012

 
October 23, 2012
Spartoo secures €25 Million in financing to accelerate European growth

 
October 22, 2012
Symetis ACURATE TF™ FIM Trial Completed

 
September 27, 2012
TAGSYS Heads up largest collaborative RFID R&D initiative with multi-million dollar SPINNAKER program

 
September 26, 2012
CeQur Completes Study Evaluating Ability of Simple Insulin Delivery Device to Replace Insulin Injections Among People with Type 2 Diabetes

 
September 20, 2012
BIND Is Granted Five U.S. Patents Covering BIND-014 and Accurin(TM) Platform

 
September 12, 2012
Amplidata Names Storage Veteran Mike Wall as New CEO, Wins Additional $6M Funding

 
August 21, 2012
Allergan and Molecular Partners Enter into Exclusive Alliance

 
July 25, 2012
Nfocus Neuromedical, Inc. Announces Positive One-Year Follow-Up Results from Clinical Study of Luna(TM) Aneurysm Embolization System

 
July 16, 2012
BIND Biosciences appoints Andrew J. Hirsch as Chief Financial Officer

 
June 22, 2012
BIND Biosciences CEO Scott Minick and Founder Omid Farokhzad Win Ernst & Young New England Entrepreneur of the Year Award

 
June 19, 2012
Oberthur Technologies completes acquisition of MoreMagic

 
June 16, 2012
Clinical Study begins on Insulin Delivery Device for Type 2s

 
June 15, 2012
OncoEthix In-Licenses OTX015, an anticancer Bromodomain inhibitor from Mitsubishi Tanabe Pharma Corporation

 
May 31, 2012
Molecular Partners AG strengthens management team with the appointment of Lisa Rojkjaer, MD as Chief Medical Officer

 
May 30, 2012
CommProve announces new channel partners

 
May 15, 2012
PneumRx, Inc. Receives FDA Approval to Commence Pivotal Clinical Trial of RePneu Lung Volume Reduction Coil (RePneu LVRC) System

 
May 11, 2012
Amplidata is object (storage) of desire for Quantum

 
May 9, 2012
Quantum to Extend Storage Solutions Leadership With Unique and Disruptive Technology for Optimizing Multi-Petabyte Size Stores

 
April 13, 2012
Franck Tetzlaff from Kobojo speaking on RTS.ch Radio show: Les temps modernes

 
April 11, 2012
Michael Wall Appointed Executive Chairman of Amplidata Board of Directors

 
April 4, 2012
BIND Biosciences Presents Clinical Data on BIND-014 Promising Anti-tumor Effects in Patients with Advanced or Metastatic Cancers

 
March 15, 2012
NEXX Systems Joins Tokyo Electron (TEL) as a Wholly Owned Subsidary

 
February 29, 2012
Amplidata closes USD 8m funding round with Big Bang Ventures, Endeavour Vision, Intel Capital and Swisscom

 
February 28, 2012
Oberthur Technologies to acquire MoreMagic, a leading Mobile Money solution provider

 
February 28, 2012
Oberthur Technologies to acquire MoreMagic, a leading Mobile Money solution provider

 
February 21, 2012
Quid listed as one of "Hottest companies in San Francisco" in Lead411 Awards

 
January 27, 2012
Daniel Bertholet of Endeavour Vision speaks at SECA event

 
January 26, 2012
Kobojo to release PyramidVille for Mobile Devices

 
December 19, 2011
CommProve achieves key milestones in 2011

 
December 8, 2011
Molecular Partners enters into a Strategic Research Collaboration and Option Agreement with Janssen Biotech, Inc. in Immunology to Develop Multispecific DARPins®

 
November 30, 2011
Kobojo opens an office in Berlin, Germany and will grow further in Europe

 
November 22, 2011
ComputerWorld: 7 hot storage startups to watch

 
November 15, 2011
CommProve launches BCN RAN Insight for real-time RAN congestion management

 
November 9, 2011
Atlantis Fantasy, the new social game of Kobojo on Facebook

 
November 3, 2011
CommProve launches CommProve NetLedge p20K solution

 
November 2, 2011
Storage Industry Veteran Mike Wall Joins Amplidata Board

 
October 27, 2011
BIND Announces New $47.25 Million Financing To Accelerate Multi-Product Pipeline

 
October 10, 2011
Dominique Pitteloud and Franck Tetzlaff from Kobojo is interviewed for nouvu.ch

 
October 10, 2011
Amplidata and École Polytechnique Fédérale de Lausanne build Live Video Archive of Montreux Jazz Festival Legends

 
September 30, 2011
Symetis’ ACURATE TA™ Aortic Bioprosthesis Receives CE Mark Certification on Sept. 30th 2011

 
September 23, 2011
Investor Allstars Awards Winners Announced

 
September 15, 2011
Kobojo sets up in Spain and expands its leadership in Latin America

 
July 25, 2011
TechCrunch: Atomico, Conway, And Founders Fund Put $10 Million Into Quid; Max Levchin Joins Board

 
July 19, 2011
Paper.li THE BLOG: One Billion Articles Featured by Paperli Publishers

 
June 1, 2011
Retailo kauft die giftmobile GmbH – und komplettiert so das Angebot

 
May 26, 2011
Ex-Electronic Arts Executive Gerhard Florin joins Kobojo

 
May 20, 2011
CommProve releases real-time RAN congestion management solution

 
May 19, 2011
Sequans Ships Ten Millionth 4G Chip

 
May 18, 2011
Symetis reports on its trans-apical ACURATE TA™ clinical

 
May 4, 2011
Allergan and Molecular Partners enter into an exclusive license agreement for MP0112 for the treatment of retinal diseases

 
April 28, 2011
Molecular Partners reports positive results from its first clinical studies

 
April 26, 2011
Kobojo completes the first round of its $7.5 million (€5.3 million) fund-raising programme with Endeavour Vision and IDinvest Partners

 
April 15, 2011
Sequans Communications Announces Pricing of Initial Public Offering

 
April 12, 2011
Amplidata and ReelData join forces to enable scalable, active archive solutions for media and entertainment

 
April 6, 2011
BIND Biosciences Receives 2011 Edison Award

 
April 5, 2011
Amplidata introduces AmpliStor, optimized object storage for massive-scale unstructured data

 
February 23, 2011
BIND Biosciences named one of MIT's Technology Review 2011 TR50 - second year in a row

 
February 16, 2011
Interview with Lars Pedersen

 
February 15, 2011
BroadHop and CommProve Team to Deliver Industry’s First End-to-End Intelligent Application and Subscriber RAN Congestion Management

 
February 15, 2011
Nfocus Neuromedical, Inc. Luna™ Aneurysm Embolization System Receives CE Mark

 
February 14, 2011
CommProve and 2operate partner to provide powerful network troublehsooting solution

 
February 11, 2011
BIND Biosciences featured in the London Times

 
February 8, 2011
Molecular Partners enters into a Strategic Research Collaboration and Option Agreement with Janssen Biotech, Inc. in Immunology to Develop Multispecific DARPins®

 
January 13, 2011
Amplidata Attacks U.S. and World Cloud Market with AmpliStor

 
January 11, 2011
SmallRivers Announces $2.1M Financing Round to Expand Paper.li Globally

 
January 7, 2011
BIND Biosciences Initiates Phase 1 Clinical Study of BIND-014

 
January 4, 2011
PneumRx, Inc. Raises $33 Million in Capital

 
April 13, 2010
CeQur SA names Robert O'Holla EVP for Regulatory Affairs

 
Zurich-Schlieren, Switzerland, December 8, 2011. Molecular Partners AG today announced that it has entered into a strategic research collaboration and option agreement with Janssen Biotech, Inc. to research, discover and develop DARPin® products for the treatment of immunological diseases. The collaboration and expansion of its current agreement with the company and its affiliates aims to explore a defined set of targets, including the use of multispecific DARPins®, to address diseases where continued unmet needs for effective treatment options continue to exist.

Under the agreement, Molecular Partners and Janssen Biotech will collaborate on research of DARPins to selected targets. During the research phase, Janssen Biotech has the right to exercise four options to exclusively license DARPin®-based products. Upon execution of each option, Janssen Biotech will be solely responsible for all clinical development, manufacturing, and commercialization activities. Molecular Par ...

more...
© Endeavour Vision SA 2006-2014 Terms & Conditions